The DOI matches its Crossref record; 363 of the 363 references it cites were found in a registry or an index.
Nicotinic acetylcholine receptors: From basic science to therapeutics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–363 of 363
Cohen, C., Bergis, O. E., Galli, F., Lochead, A. W., Jegham, S., Biton, B., Léonardon, J., Avenet, P., Sgard, F., Besnard, F., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049262 · Cited by 114
Gatto, G. J., Bohme, G. A., Caldwell, W. S., Letchworth, S. R., Traina, V. M., Obinu, M. C., Laville, M., Reibaud, M., Pradier, L., Dunbar, G., et al. (2004) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2004.tb00010.x · Cited by 111
The α9α10 nicotinic acetylcholine receptor is permeable to and is modulated by divalent cations
Weisstaub, N., Vetter, D. E., Elgoyhen, A. B., & Katz, E. (2002) · Hearing Research · doi:10.1016/s0378-5955(02)00380-5 · Cited by 111
Han, Z., Zoli, M., Cardona, A., Bourgeois, J., Changeux, J., & Novère, N. G. L. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10659 · Cited by 111
Potter, A., NEWHOUSE, P. A., & Bucci, D. J. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.09.015 · Cited by 111
Ericson, M., Löf, E., Stomberg, R., & Söderpalm, B. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147058 · Cited by 110
Hendrickson, L. M., Zhao-Shea, R., Pang, X.-Y., Gardner, P. D., & Tapper, A. R. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2601-10.2010 · Cited by 109
Chini, B., Clementi, F., Hukovic, N., & Sher, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1572 · Cited by 109
Perry, D. C., Mao, D., Gold, A. B., McIntosh, J. M., Pezzullo, J. C., & Kellar, K. J. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121228 · Cited by 106
Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in Schizophrenia
Tregellas, J. R., Tanabe, J., Rojas, D. C., Shatti, S., D, A. O. M., Johnson, L. L., Martín, L., Soti, F. S., Kem, W. R., Leonard, S. S., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.004 · Cited by 106
Chatterjee, S., Steensland, P., Simms, J. A., Holgate, J. Y., Coe, J. W., Hurst, R. S., Shaffer, C. L., Lowe, J. A., III, Rollema, H., & Bartlett, S. E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.191 · Cited by 105
Self-citationWouda, J. A., Riga, D., de Vries, W., Stegeman, M., van Mourik, Y., Schetters, D., Schoffelmeer, A. N. M., Pattij, T., & Vries, T. J. D. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2213-8 · Cited by 104
Donnelly‐Roberts, D. L., Puttfarcken, P. S., Kuntzweiler, T. A., Briggs, C. A., Anderson, D. J., Campbell, J. E., Piattoni-Kaplan, M., McKenna, D. G., Wasicak, J. T., Holladay, M. W., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37422-1 · Cited by 103
Chatterjee, S., & Bartlett, S. E. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710790966597 · Cited by 103
Expression of an α7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytes
Villiger, Y., Szántó, I., Jaconi, S., Blanchet, C., Buisson, B., Krause, K.-H., Bertrand, D., & Romand, J.-A. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00057-7 · Cited by 103
Self-citationYu, C., & Role, L. W. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.667bm.x · Cited by 102
Nicotinic actions on neuronal networks for cognition: General principles and long-term consequences
Poorthuis, R. B., Goriounova, N. A., Couey, J. J., & Mansvelder, H. D. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.031 · Cited by 102
The Expression and Functional Role of Nicotinic Acetylcholine Receptors in Rat Adipocytes
Liu, R., Mizuta, M., & Matsukura, S. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.065037 · Cited by 102
Andreasen, J., Olsen, G., Wiborg, O., & Redrobe, J. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108091587 · Cited by 101
Elliott, K. J., Ellis, S. B., Berckhan, K. J., Urrutia, A., Chavez-Noriega, L. E., Johnson, E. C., Veliçelebi, G., & Harpold, M. M. (1996) · Journal of Molecular Neuroscience · doi:10.1007/bf02736842 · Cited by 101
Neurotransmitter and Receptor Deficits in Senile Dementia of the Alzheimer Type
Quirion, R., Martel, J.-C., Robitaille, Y., Etienne, P. E., Wood, P. L., Nair, N. P. V., & Gauthier, S. G. (1986) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100037215 · Cited by 100
Kem, W. R., Mahnir, V. M., Prókai, L., Papke, R. L., Cao, X., LeFrancois, S., Wildeboer, K. M., Prókai-Tátrai, K., Porter-Papke, J., & Soti, F. S. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.56 · Cited by 100
Sydserff, S. G., Sutton, E. J., Song, D., Quirk, M. C., Maciag, C. M., Li, Z., Jonak, G. J., Gurley, D. A., Gordon, J. C., Christian, E. P., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.005 · Cited by 98
Bitner, R. S., Bunnelle, W. H., Decker, M. W., Drescher, K. U., Kohlhaas, K. L., Markosyan, S., Marsh, K. C., Nikkel, A. L., Browman, K., Radek, R., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167213 · Cited by 97
Walker, D. P., Wishka, D. G., Piotrowski, D. W., Jia, S., Reitz, S. C., Yates, K. M., Myers, J. K., Vetman, T. N., Margolis, B. J., Jacobsen, E. J., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.019 · Cited by 95
Self-citationPotentiation of Human α4β2 Neuronal Nicotinic Acetylcholine Receptor by Estradiol
Curtis, L., Buisson, B., Bertrand, S., & Bertrand, D. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.127 · Cited by 95
Self-citationRezvani, A. H., Kholdebarin, E., Brucato, F. H., Callahan, P. M., Lowe, D., & Levin, E. D. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.018 · Cited by 94
Champtiaux, N., & Changeux, J. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339247 · Cited by 92
Castner, S. A., Smagin, G. N., Piser, T. M., Wang, Y., Smith, J. S., Christian, E. P., Mrzljak, L., & Williams, G. V. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.006 · Cited by 90
Turner, J. R., Castellano, L. M., & Blendy, J. A. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166280 · Cited by 88
Toll, L., Zaveri, N. T., Polgar, W. E., Jiang, F., Khroyan, T. V., Zhou, W., Xie, X., Stauber, G. B., Costello, M. R., & Leslie, F. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.322 · Cited by 88
Arredondo, J., Chernyavsky, A. I., Jolkovsky, D. L., Pinkerton, K. E., & Grando, S. A. (2007) · The FASEB Journal · doi:10.1096/fj.07-9965.com · Cited by 88
Up-regulation of Nicotinic Receptors by Nicotine Varies with Receptor Subtype
Walsh, H., Govind, A. P., Mastro, R., Hoda, J. C., Bertrand, D., Vallejo, Y., & Green, W. N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m703432200 · Cited by 87
Self-citationRollema, H., Guanowsky, V., Mineur, Y. S., Shrikhande, A., Coe, J. W., Seymour, P. A., & Picciotto, M. R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.01.002 · Cited by 87
Self-citationVarenicline Augmentation in Depressed Smokers: An 8-Week, Open-Label Study
Philip, N. S., Carpenter, L. L., Tyrka, A. R., Whiteley, L. B., & Price, L. H. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04441 · Cited by 86
TC‐5214 (S‐(+)‐Mecamylamine): A Neuronal Nicotinic Receptor Modulator with Antidepressant Activity
Lippiello, P. M., Beaver, J. S., Gatto, G. J., James, J. W., Green-Jordan, K., Traina, V. M., Xie, J., & Bencherif, M. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00054.x · Cited by 85
Neuronal nicotinic acetylcholine receptors: From the genetic analysis to neurological diseases
Steinlein, O. K., & Bertrand, D. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.012 · Cited by 84
Self-citationToyohara, J., Sakata, M., Wu, J., Ishikawa, M., Oda, K., Ishii, K., Iyo, M., Hashimoto, K., & Ishiwata, K. (2009) · Annals of Nuclear Medicine · doi:10.1007/s12149-009-0240-x · Cited by 84
Nicotine Vaccines to Assist with Smoking Cessation: Current Status of Research
Raupach, T., Hoogsteder, P., & van Schayck, O. C. P. (2012) · Drugs · doi:10.2165/11599900-000000000-00000 · Cited by 83
Papke, R. L., Dwoskin, L. P., & Crooks, P. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04355.x · Cited by 83
Ulens, C., Akdemir, A., Jongejan, A., van Elk, R., Bertrand, S., Anastassis Perrakis, A., Leurs, R., Smit, A. B., Sixma, T. K., Bertrand, D., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801400g · Cited by 83
Self-citationFrom ligand design to therapeutic efficacy: the challenge for nicotinic receptor research
Cassels, B. K., Bermúdez, I., Dajas, F., Abin‐Carriquiry, J. A., & Wonnacott, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03665-2 · Cited by 81
Greenbaum, L., & Lerer, B. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.59 · Cited by 81
(2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7 · Cited by 79
Buccafusco, J. J., & Terry, A. V. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.102 · Cited by 79
Huang, L. Z., Campos, C., Ly, J., Carroll, F. I., & Quik, M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.032 · Cited by 79
Papke, R. L., Dwoskin, L. P., Crooks, P. A., Zheng, G., Zhang, Z., McIntosh, J. M., & Stokes, C. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.03.010 · Cited by 79
Turner, J. R., Castellano, L. M., & Blendy, J. A. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq206 · Cited by 78
Bannon, A. W., Decker, M. W., Curzon, P., Buckley, M. J., Kim, D. J. B., Radek, R. J., Lynch, J. K., Wasicak, J. T., Lin, N., Arnold, W. H., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37423-3 · Cited by 78
Targeting α7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia
Hajós, M., & Rogers, B. N. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361434 · Cited by 77
Positive and negative modulation of nicotinic receptors
Arias, H. R. (2010) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-381264-3.00005-9 · Cited by 76
O’Donnell, C. J., Rogers, B. N., Bronk, B. S., Bryce, D. K., Coe, J. W., Cook, K. K., Duplantier, A. J., Evrard, E., Hajós, M., Hoffmann, W. E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9015075 · Cited by 76
Self-citationCytisine-based nicotinic partial agonists as novel antidepressant compounds
Mineur, Y. S., Eibl, C., Young, G., Kochevar, C., Papke, R. L., Gündisch, D., & Picciotto, M. R. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.149609 · Cited by 75
Colomer, C., Olivos-Oré, L. A., Vincent, A., McIntosh, J. M., Artalejo, A. R., & Guérineau, N. C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4997-09.2010 · Cited by 73
Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors
Hogg, R. C., & Bertrand, D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.010 · Cited by 72
Self-citationResults of an initial clinical trial of varenicline for the treatment of cocaine dependence
Plebani, J. G., Lynch, K. G., Yu, Q. P., Pettinati, H. M., O’Brien, C. P., & Kampman, K. M. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.08.025 · Cited by 71
Grishin, A. A., Wang, C.-I. A., Muttenthaler, M., Alewood, P. F., Lewis, R. J., & Adams, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.111880 · Cited by 71
Gotti, C., Moretti, M., Zanardi, A., Gaimarri, A., Champtiaux, N., Changeux, J., Whiteaker, P., Marks, M. J., Clementi, F., & Zoli, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015925 · Cited by 71
Crunelle, C. L., Miller, M. L., Booij, J., & van den Brink, W. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.11.001 · Cited by 70
Marks, M. J., McClure-Begley, T. D., Whiteaker, P., Salminen, O., Brown, R. W. B., Cooper, J., Collins, A. C., & Lindstrom, J. M. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.178236 · Cited by 70
Krashia, P., Moroni, M., Broadbent, S. D., Hofmann, G., Kracun, S., Beato, M., Groot‐Kormelink, P. J., & Sivilotti, L. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013611 · Cited by 70
Poling, J. C., Rounsaville, B. J., Gonsai, K., Severino, K., & Sofuoglu, M. (2010) · American Journal on Addictions · doi:10.1111/j.1521-0391.2010.00066.x · Cited by 69
Cancello, R., Zulian, A., Maestrini, S., Mencarelli, M., Barba, A. D., Invitti, C., Liuzzi, A., & Blasio, A. M. D. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.275 · Cited by 69
Gurun, M. S., Parker, R., Eisenach, J. C., & Vincler, M. A. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31819dcd08 · Cited by 68
Conductances of single ion channels opened by nicotinic agonists are indistinguishable
Gardner, P. I., Ogden, D., & Colquhoun, D. (1984) · Nature · doi:10.1038/309160a0 · Cited by 68
Gao, B.-X., Hierl, M., Clarkin, K., Juan, T., Nguyen, H. Q., van der Valk, M., Deng, H. X., Guo, W., Lehto, S. G., Matson, D. J., et al. (2010) · Pain · doi:10.1016/j.pain.2010.01.007 · Cited by 67
Why doesn't nicotinic ACh receptor immunoreactivity knock out?
JONES, I., & Wonnacott, S. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.04.010 · Cited by 67
Parri, H. R., & Dineley, K. T. (2010) · Current Alzheimer Research · doi:10.2174/156720510790274464 · Cited by 67
Brown, D. A., Docherty, R. J., & Halliwell, J. V. (1984) · The Journal of Physiology · doi:10.1113/jphysiol.1984.sp015325 · Cited by 66
van Nierop, P., Bertrand, S., Munno, D. W., Gouwenberg, Y., van Minnen, J., Spafford, J. D., Syed, N. I., Bertrand, D., & Smit, A. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508571200 · Cited by 66
Self-citationGroot‐Kormelink, P. J., Boorman, J. P., & Sivilotti, L. G. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704313 · Cited by 64
Neuronal Nicotinic Receptor Subtypes: DEFINING THERAPEUTIC TARGETS
Buccafusco, J. J. (2004) · Molecular Interventions · doi:10.1124/mi.4.5.8 · Cited by 64
Lee, C., Zhu, C., Malysz, J., Campbell, T., Shaughnessy, T. K., Honoré, P., Polakowski, J. S., & Gopalakrishnan, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.044 · Cited by 64
Frölich, L., on behalf of the Sirocco Investigators, Ashwood, T. J., Nilsson, J., & Eckerwall, G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101554 · Cited by 63
Creating an α7 Nicotinic Acetylcholine Recognition Domain from the Acetylcholine-binding Protein
Nemecz, Á., & Taylor, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.286583 · Cited by 63
Perez, X. A., Bordia, T., McIntosh, J. M., & Quik, M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.067561 · Cited by 62
Grady, S. R., Salminen, O., McIntosh, J. M., Marks, M. J., & Collins, A. C. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9263-y · Cited by 61
Effects of Quinine, Quinidine, and Chloroquine on α9α10 Nicotinic Cholinergic Receptors
Ballestero, J. A., Plazas, P. V., Kracun, S., Gómez‐Casati, M. E., Taranda, J., Rothlin, C. V., Katz, E., Millar, N. S., & Elgoyhen, A. B. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014431 · Cited by 61
Broadbent, S. D., Groot‐Kormelink, P. J., Krashia, P., Harkness, P. C., Millar, N. S., Beato, M., & Sivilotti, L. G. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026682 · Cited by 60
Barak, S., Arad, M., Levie, A. D., Black, M. D., Griebel, G., & Weiner, I. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.232 · Cited by 59
Nicotinic receptor channelopathies and epilepsy
Steinlein, O. K., & Bertrand, D. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0766-8 · Cited by 59
Self-citationHoft, N. R., Corley, R. P., McQueen, M. B., Huizinga, D. H., Menard, S., & Ehringer, M. A. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00495.x · Cited by 58
A prokaryotic perspective on pentameric ligand-gated ion channel structure
Hilf, R. J. C., & Dutzler, R. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.07.006 · Cited by 58
Shytle, R. D., Silver, A. A., Wilkinson, B. J., & Sanberg, P. R. (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150616 · Cited by 56
Bain, E., Robieson, W., Pritchett, Y., Garimella, T. S., Abi‐Saab, W., Apostol, G., McGough, J. J., & Saltarelli, M. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.194 · Cited by 56
Zaveri, N. T., Jiang, F., Olsen, C. M., Polgar, W. E., & Toll, L. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1006148 · Cited by 55
Activation and inhibition of rat neuronal nicotinic receptors by ABT‐418
Papke, R. L., Thinschmidt, J. S., Moulton, B., Meyer, E. M., & Poirier, A. E. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700930 · Cited by 55
Apostol, G., Abi‐Saab, W., Kratochvil, C. J., Adler, L. A., Robieson, W., Gault, L. M., Pritchett, Y., Feifel, D., Collins, M. A., & Saltarelli, M. D. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2393-2 · Cited by 53
Anderson, D. J., Bunnelle, W. H., Surber, B. W., Du, J. Y., Surowy, C. S., Tribollet, E., Marguerat, A., Bertrand, D., & Gopalakrishnan, M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.130062 · Cited by 52
Self-citationHosur, V., & Loring, R. H. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066381 · Cited by 52
Zhu, C., Chin, C., Rustay, N. R., Zhong, C., Mikusa, J. P., Chandran, P., Salyers, A. K., Gomez, E. J., Simler, G. H., Lewis, L. G. R., et al. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.05.007 · Cited by 51
Crystal Structures of a Cysteine-modified Mutant in Loop D of Acetylcholine-binding Protein
Brams, M., Gay, E. A., Colón‐Sáez, J. O., Guskov, A., van Elk, R., van der Schors, R. C., Peigneur, S., Tytgat, J., Strelkov, S. V., Smit, A. B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188730 · Cited by 51
RJR-2403: a nicotinic agonist with CNS selectivity II. In vivo characterization.
Lippiello, P. M., Bencherif, M., Gray, J. A., Peters, S., Grigoryan, G. A., Hodges, H., & Collins, A. C. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21303-9 · Cited by 51
Malysz, J., Anderson, D. J., Grønlien, J. H., Ji, J., Bunnelle, W. H., Håkerud, M., Thorin-Hagene, K., Ween, H., Helfrich, R., Hu, M., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167072 · Cited by 50
Mineur, Y. S., Einstein, E. B., Seymour, P. A., Coe, J. W., O'Neill, B. T., Rollema, H., & Picciotto, M. R. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328347546d · Cited by 49
Self-citationSLURP1 mutation-impaired T-cell activation in a family with mal de Meleda
Tjiu, J.-W., Lin, P., Wu, W., Cheng, Y.-P., Chiu, H., Thong, H.-Y., Chiang, B., Yang, W., & Jee, S. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10059.x · Cited by 49
Randomized placebo-controlled study of the nicotinic agonist SIB-1508Y in Parkinson disease
The Parkinson Study Group (2006) · Neurology · doi:10.1212/01.wnl.0000196466.99381.5c · Cited by 49
Caldarone, B. J., Wang, D., Paterson, N. E., Manzano, M., Fedolak, A., Cavino, K., Kwan, M., Hanania, T., Chellappan, S. K., Kozikowski, A. P., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2271-y · Cited by 47
Christensen, D. Z., Mikkelsen, J. D., Hansen, H. H., & Thomsen, M. S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06845.x · Cited by 47
Covernton, P. J. O., & Connolly, J. G. (2000) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(99)00185-5 · Cited by 46
Anderson, D. J., Malysz, J., Grønlien, J. H., El Kouhen, R., Håkerud, M., Wetterstrand, C., Briggs, C. A., & Gopalakrishnan, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.024 · Cited by 44
α7 Nicotinic Receptor Agonists as Potential Therapeutic Drugs for Schizophrenia
Hashimoto, K., Koike, K., Shimizu, E., & Iyo, M. (2005) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1568015054863828 · Cited by 44
Dunbar, G. C., Kuchibhatla, R., & Lee, G. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110367727 · Cited by 44
Maloku, E., Kadriu, B., Zhubi, A., Dong, E., Pibiri, F., Satta, R., & Guidotti, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.21 · Cited by 44
Bencherif, M. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.37 · Cited by 44
Grinevich, V. P., Letchworth, S. R., Lindenberger, K. A., Ménager, J., Mary, V., Sadieva, K. A., Buhlman, L. M., Böhme, G. A., Pradier, L., Bénavidès, J., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075069 · Cited by 44
The neuronal nicotinic α4β2 receptor has a high maximal probability of being open
Li, P., & Steinbach, J. H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00761.x · Cited by 43
Gould, R. W., Czoty, P. W., Nader, S. H., & Nader, M. A. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.185538 · Cited by 43
Modulators of nicotinic acetylcholine receptors as analgesics.
Jain, K. K. (2004) · PubMed · Cited by 42
Hurst, L. D. (2011) · Nature · doi:10.1038/471582a · Cited by 41
Evans, N. M., Bose, S., Benedetti, G., Zwart, R., Pearson, K. H., McPhie, G. I., Craig, P. J., Benton, J. P., Volsen, S. G., Sher, E., et al. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01540-1 · Cited by 41
Jin, X., & Steinbach, J. H. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4802-10.2011 · Cited by 41
Mechanism of action of A-85380 in an animal model of depression
Buckley, M. J., Surowy, C. S., Meyer, M., & Curzon, P. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.012 · Cited by 39
Kamens, H. M., Andersen, J., & Picciotto, M. R. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01301.x · Cited by 38
Eng, C. M., Kozak, C. A., Beaudet, A. L., et al. (1991) · Genomics · doi:10.1016/0888-7543(91)90253-b · Cited by 38
Armishaw, C. J. (2010) · Toxins · doi:10.3390/toxins2061471 · Cited by 37
Gilles, C., & Luthringer, R. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077733 · Cited by 37
Kozikowski, A. P., Eaton, J. B., Bajjuri, K. M., Chellappan, S. K., Chen, Y., Karadi, S., He, R., Caldarone, B., Manzano, M., Yuen, P., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200900079 · Cited by 36
Arias, H. R., Rosenberg, A., Targowska‐Duda, K. M., Feuerbach, D., Jóźwiak, K., Moaddel, R., & Wainer, I. W. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.03.002 · Cited by 36
Fedorov, N. B., Benson, L. C., Graef, J. D., Lippiello, P. M., & Bencherif, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146910 · Cited by 36
Arnerić, S. P., Sullivan, J. P., Briggs, C. A., Donnelly‐Roberts, D. L., Anderson, D. J., Raszkiewicz, J. L., Hughes, M. L., Cadman, E. D., Adams, P., & Garvey, D. S. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22334-5 · Cited by 36
Werkheiser, J. L., Sydserff, S. G., Hubbs, S. J., Ding, M., Eisman, M. S., Perry, D., Williams, A., Smith, J. S., Mrzljak, L., & Maier, D. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.033 · Cited by 35
Brumwell, C. L., Johnson, J. L., & Jacob, M. H. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-18-08101.2002 · Cited by 35
Wilens, T. E., Gault, L. M., Childress, A. C., Kratochvil, C. J., Bensman, L., Hall, C. M., Olson, E., Robieson, W., Garimella, T. S., Abi‐Saab, W., et al. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.10.001 · Cited by 34
Neuronal Nicotinic Receptors as Brain Targets for Pharmacotherapy of Drug Addiction
Rahman, S., López‐Hernández, G. Y., Corrigall, W. A., & Papke, R. L. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927831 · Cited by 34
Block of the α9 nicotinic receptor by ototoxic aminoglycosides
Rothlin, C. V., Katz, E., Verbitsky, M., Vetter, D. E., Heinemann, S. F., & Elgoyhen, A. B. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00056-3 · Cited by 33
Rueter, L. E., Donnelly‐Roberts, D. L., Curzon, P., Briggs, C. A., Anderson, D. J., & Bitner, R. S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00100.x · Cited by 33
In vivo labeling of nicotinic cholinergic receptors in brain with [3H]cytisine
Flesher, J. E., Scheffel, U., London, E. D., & Frost, J. J. (1994) · Life Sciences · doi:10.1016/0024-3205(94)90146-5 · Cited by 32
Developmental Expression of Heteromeric Nicotinic Receptor Subtypes in Chick Retina
Vailati, S., Moretti, M., Longhi, R., Rovati, G. E., Clementi, F., & Gotti, C. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1329 · Cited by 32
Psychosurgery and deep brain stimulation as ultima ratio treatment for refractory depression
Juckel, G., Uhl, I., Padberg, F., Brüne, M., & Winter, C. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-0826-7 · Cited by 32
Pleiotropic functional effects of the first epilepsy‐associated mutation in the human CHRNA2 gene
Hoda, J., Wanischeck, M., Bertrand, D., & Steinlein, O. K. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.04.024 · Cited by 31
Self-citationSelectivity of ABT-089 for α4β2* and α6β2* nicotinic acetylcholine receptors in brain
Marks, M. J., Wageman, C. R., Grady, S. R., Gopalakrishnan, M., & Briggs, C. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.022 · Cited by 30
Boorman, J. P., Beato, M., Groot‐Kormelink, P. J., Broadbent, S. D., & Sivilotti, L. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211719200 · Cited by 29
Combined effects of nicotine and mecamylamine in attenuating smoking satisfaction.
Rose, J. E., Behm, F. M., Westman, E. C., Levin, E. D., STEIN, R. M., Lane, J. D., & Ripka, G. V. (1994) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.2.4.328 · Cited by 27
Riganti, L., Matteoni, C., Angelantonio, S. D., Nistri, A., Gaimarri, A., Sparatore, F., Canu, C., Clementi, F., & Gotti, C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706434 · Cited by 27
Liu, Q., Yu, K., Chang, Y., Lukas, R. J., & Wu, J. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00760.x · Cited by 25
Tonstad, S., Holme, I., & Tønnesen, P. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq191 · Cited by 25
Fahim, R. E. F., Kessler, P., Fuller, S. A., & Kalnik, M. W. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711799219343 · Cited by 24
Kucinski, A. J., Stachowiak, M. K., Wersinger, S. R., Lippiello, P. M., & Bencherif, M. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111794480589 · Cited by 23
Cosford, N. D. P., Bleicher, L. S., Vernier, J., Chavez-Noriega, L. E., Rao, T. S., Siegel, R. S., Suto, C. M., Washburn, M. S., Lloyd, G. K., & McDonald, I. A. (2000) · Pharmaceutica Acta Helvetiae · doi:10.1016/s0031-6865(99)00024-2 · Cited by 22
Nicotinic Acetylcholine Receptors and Modulation of Learning in 4- and 27-Month-Old Rabbits
Li, J., Lehr, M. A., Liu‐Chen, L., & Woodruff‐Pak, D. S. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.1 · Cited by 22
Neuronal Nicotinic Acetylcholine Receptor Modulators: Recent Advances and Therapeutic Potential
Breining, S. R., Mazurov, A. A., & Miller, C. H. (2005) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(05)40001-9 · Cited by 21
Varenicline effects on cocaine self administration and reinstatement behavior
Guillem, K., & Peoples, L. L. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328336e9c5 · Cited by 21
Ding, M., Ghanekar, S. V., Elmore, C. S., Zysk, J. R., Werkheiser, J. L., Lee, C., Liu, J., Chhajlani, V., & Maier, D. L. (2011) · Synapse · doi:10.1002/syn.21513 · Cited by 21
Hansen, C. P., Jensen, A. A., Christensen, J. K., Balle, T., Liljefors, T., & Frølund, B. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701625v · Cited by 21
Voß, B., Thienel, R., Reske, M., Habel, U., & Kircher, T. T. J. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0160-8 · Cited by 20
Holtman, J. R., Crooks, P. A., Hardy, J. K., & Wala, E. P. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.09.017 · Cited by 19
Stitzel, J. A. (2007) · Frontiers in bioscience · doi:10.2741/2694 · Cited by 18
Pilot safety evaluation of varenicline for the treatment of methamphetamine dependence
Zorick, T. S. (2009) · Journal of Experimental Pharmacology · doi:10.2147/jep.s8356 · Cited by 18
Characterisation of nicotine receptors on human peripheral blood mononuclear cells (PBMC)
Wongsriraksa, A., Parsons, M. E., & Whelan, C. J. (2009) · Inflammation Research · doi:10.1007/s00011-008-8171-x · Cited by 17
Poisik, O. V., Shen, J., Jones, S., & Yakel, J. L. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.149963 · Cited by 17
Dwoskin, L. P., & Bardo, M. T. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.157 · Cited by 15
Neuronal nAChR stereoselectivity to non‐natural epibatidine derivatives
Bertrand, S., Patt, J. T., Spang, J. E., Westera, G., Schubiger, P. A., & Bertrand, D. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00473-1 · Cited by 15
Self-citationSchröder, H., Schütz, U., Burghaus, L., Lindstrom, J. M., Kuryatov, A., Monteggia, L. M., deVos, R. A. I., van Noort, G., Wevers, A., Nowacki, S., et al. (2001) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00293-0 · Cited by 14
Gahring, L. C., & Rogers, S. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105346 · Cited by 12
Focus on α4β2* and α6β2* nAChRs for Parkinson's Disease Therapeutics.
Perez, X. A., & Quik, M. (2011) · PubMed · Cited by 12
Nicotinic Receptor Antagonists in Rats
Levin, E. D., & Buccafusco, J. J. (2006) · CRC Press eBooks · doi:10.1201/9781420004335-8 · Cited by 12
Zambrano, C. A., Marks, M. J., Cassels, B. K., & Maccioni, R. B. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.05.004 · Cited by 11
Genetic association of bipolar disorder with the β3 nicotinic receptor subunit gene
Hartz, S. M., Lin, P., Edenberg, H. J., Xuei, X., Rochberg, N., Saccone, S. F., Berrettini, W. H., Nelson, E. C., Nürnberger, J. I., Bierut, L. J., et al. (2010) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32834135eb · Cited by 10
Rao, T. S., Adams, P. B., Correa, L. D., Santori, E. M., Sacaan, A. I., Reid, R. T., & Cosford, N. D. P. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.063 · Cited by 10
Nicotine Conjugate Vaccine as a Novel Approach to Smoking Cessation
Ottney, A. R. (2011) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.31.7.703 · Cited by 7
Spoettl, T., Paetzel, C., Herfarth, H. H., Bencherif, M., Schöelmerich, J., Greinwald, R., Gatto, G. J., & Rogler, G. (2006) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0135-4 · Cited by 6
Nicotinic Receptor Subunit mRNA Expression in Dopaminergic Neurons of the Rat Brain
Sgard, F., Charpantier, E., Barnéoud, P., & Besnard, F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb11338.x · Cited by 6
Cited by
Nicotinic ACh receptors as therapeutic targets in CNS disorders
Dineley, K. T., Pandya, A. A., & Yakel, J. L. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.12.002 · Cited by 450
Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies
Oyrer, J., Maljevic, S., Scheffer, I. E., Berkovic, S. F., Petrou, S., & Reid, C. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014456 · Cited by 315
Watson, H. (2015) · Essays in Biochemistry · doi:10.1042/bse0590043 · Cited by 303
Diversity of native nicotinic receptor subtypes in mammalian brain
Zoli, M., Pistillo, F., & Gotti, C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.003 · Cited by 277
Cognitive Effects of Nicotine: Recent Progress
Valentine, G., & Sofuoglu, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171103152136 · Cited by 271
Metadata
- Authors
- Hurst, R., Rollema, H., & Bertrand, D.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 137
- Issue
- 1
- Pages
- 22-54
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2060488758
- Cited by
- 522
- References
- 363
- FWCI
- 16.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.